Transforming health care through research and education.
Leveraging research and education to create a society of healthy communities, where all individuals reach their highest potential for health.
A Package of Tools for Providers to Improve Quality of Care and Maximize Reimbursement
|Click here to print the entire guide|
The Centers for Disease Control and Prevention (CDC) recommends routine HIV screening of all adults, regardless of risk. A critical part of developing and sustaining a screening program is integrating it into the mission of the organization in a financially prudent manner.
In addition to the CDC guidelines, the U. S. Preventive Services Task Force (USPSTF) gives an "A" recommendation for screening patients who are at risk for HIV, as well as any patient who requests a test. Several clinical specialty societies also support routine screening.
This package of information on HIV testing and screening, including cost and reimbursement tools, assists clinical managers and individual practitioners in starting or expanding an HIV screening or diagnostic testing program. The scope of these resources is limited to screening and testing, and does not explore linkage-to-care issues.
Who Should Use This Guide
This information is designed for health care providers who are not necessarily experts on HIV, finance or reimbursement, and serves as a guide to asking the right questions in each health system, hospital or clinic. Because each provider is different, it is difficult to present precise cost and reimbursement information specific to each organization. However, the broad list of issues presented serves as a framework for further research and discussion in an institution. The information is relevant to for:
HIV in the United States
The CDC estimates:
CDC and USPSTF Recommendations
In part, the CDC recommends routine, voluntary HIV screening for:
For a complete list of CDC's recommendations, go to Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. In addition, CDC offers resources for primary care providers here.
For the USPSTF recommendations, go to Screening: Human Immunodeficiency Virus.
This Package Includes
The tools in this package of cost and reimbursement materials include:
For more information, contact Awo Osei-Anto, Researcher, Health Research & Educational Trust, email@example.com or (312) 422-2642.
This resource is made possible through funding from the Center for Disease Control and Prevention; National Center for HIV/AIDS, STD and TB Prevention, Division of HIV/AIDS Prevention, through Cooperative Agreement Number 5U65PS000818-04. Its content are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.
Miller, J; Hund, C; Akamigbo, A; HIV Testing and Screening Cost and Reimbursement Toolkit. www.hret.org/hiv-cost accessed on date
©2006-2017 by the American Hospital Association. All rights reserved. Noncommercial use of original content on www.aha.org is granted to AHA Institutional Members, their employees and State, Regional and Metro Hospital Associations unless otherwise indicated. AHA does not claim ownership of any content, including content incorporated by permission into AHA produced materials, created by any third party and cannot grant permission to use, distribute or otherwise reproduce such third party content. To request permission to reproduce AHA content, please click here.